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Abstract
Background: Directed differentiation of human induced pluripotent stem cells (hiPSC) into functional, region-specific neural
cells is a key step to realizing their therapeutic promise to treat various neural disorders, which awaits detailed elucidation.
Methodology/Principal Findings: We analyzed neural differentiation from various hiPSC lines generated by others and
ourselves. Although heterogeneity in efficiency of neuroepithelial (NE) cell differentiation was observed among different
hiPSC lines, the NE differentiation process resembles that from human embryonic stem cells (hESC) in morphology, timing,
transcriptional profile, and requirement for FGF signaling. NE cells differentiated from hiPSC, like those from hESC, can also
form rostral phenotypes by default, and form the midbrain or spinal progenitors upon caudalization by morphogens. The
rostrocaudal neural progenitors can further mature to develop forebrain glutamatergic projection neurons, midbrain
dopaminergic neurons, and spinal motor neurons, respectively. Typical ion channels and action potentials were recorded in
the hiPSC-derived neurons.
Conclusions/Significance: Our results demonstrate that hiPSC, regardless of how they were derived, can differentiate into a
spectrum of rostrocaudal neurons with functionality, which supports the considerable value of hiPSC for study and
treatment of patient-specific neural disorders.
Citation: Zeng H, Guo M, Martins-Taylor K, Wang X, Zhang Z, et al. (2010) Specification of Region-Specific Neurons Including Forebrain Glutamatergic Neurons
from Human Induced Pluripotent Stem Cells. PLoS ONE 5(7): e11853. doi:10.1371/journal.pone.0011853
Editor: Thomas A. Reh, University of Washington, United States of America
Received January 25, 2010; Accepted July 7, 2010; Published July 29, 2010
Copyright:  2010 Zeng et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Ren-He Xu: Connecticut Stem Cell Research Grants (http://www.ct.gov/dph/cwp/view.asp?a=3142&q=389700, #06SCD02 and 06SCB14). Xue-Jun Li:
National Institutes of Health grant (http://grants.nih.gov/grants/funding/r21.htm, #R21 NS055261) and University of Connecticut Health Center start-up funds.
Hui Zeng and Min Guo: China Scholarship Council funds (http://www.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision
to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: renhexu@uchc.edu (RHX); xjli@uchc.edu (XJL)
. These authors contributed equally to this work.
Introduction
Embryonic stem (ES) cells have been derived from mouse,
monkey, human, and many other species, and considered as
potent candidates for regenerative medicine, and unique tools for
understanding of disease mechanisms and screening for effective
and safe drugs[1]. The key step toward their application in
neurological diseases is to direct human ES cell (hESC)
differentiation to the neural lineages and then to specific neuronal
types that are affected under certain pathological conditions[2].
Since the seminal reports on neural differentiation in 2001[3],
efficient neural differentiation has been achieved using several
systems involving adherent culture[4], embryoid body (EB)
formation[3,5], and/or co-culture with stromal cells[6,7]. Neuro-
genesis occurs when bone morphogenetic protein (BMP) signaling
is inhibited, as we[8] and others[9,10] first demonstrated in the
Xenopus embryo, and/or when fibroblast growth factor (FGF)
signaling is activated[11]. Recently, it was reported that FGF
alone promotes neural differentiation from hESC, independently
of BMP signaling[12].
During development, specific neural progenitors are induced
along anterior-posterior (or rostral-caudal) and dorsal-ventral axes
by secreted morphogens[13,14]. Currently, protocols for generat-
ing neuronal subtypes have been developed largely based on the
positional information of these cell types in vivo. The utilization of
the morphogens such as sonic hedgehog (SHH) plus retinoic acid
(RA) or SHH plus FGF8 has made it possible to produce spinal
motor neurons and midbrain dopaminergic neurons, respectively,
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that forebrain glutamatergic and GABAnergic neurons can be
specified from hESC-derived neuroepithelial (NE) cells via
modulation of WNT and SHH pathways[21]. Although hESC-
derived neurons provide an important tool for studying neural
genetic disorders and producing therapeutic cell types for their
treatment, these applications are only possible after the difficulties
of genetically manipulating hESC to model the diseases and the
problem of immunorejection of hESC-derived cells by potential
recipients are overcome.
The breakthroughs in generation of induced pluripotent stem
cell (iPSC) via somatic cell reprogramming[22,23,24,25] have
made it possible to obtain human iPSC (hiPSC) from patients such
as those with Parkinson disease[26] and amyotrophic lateral
sclerosis[27]. These cells have the same genetic background as the
patients, thus possessing tremendous potential to model the
neurological diseases and generate patient-specific neurons for
autogenous transplantation[28,29]. hESC[30] and hiPSC[22,23]
are derived from totally different tissues and via different methods.
They have been demonstrated to possess quite different gene
expression profiles, despite great similarities in the expression
patterns of pluripotency and developmental genes between both
cell types[31]. Thus, it is very important to examine whether
hiPSC have the same capacity to generate the whole spectrum of
region-specific neural progenitors and then functional neuronal
subtypes. Here, we demonstrate the efficient patterning of hiPSC-
derived NE cells to region-specific progenitors along the anterior-
posterior axis, which can further differentiate into functional
neurons including forebrain glutamatergic neurons. Different
hiPSC lines showed marked variations in the generation of NE
cells, suggesting that intrinsic differences between hiPSC lines are
in play.
Methods
Ethics Statement
All animal work was conducted according to relevant national
and international guidelines (see details under the section of
‘‘hiPSC Generation’’).
Reagents
Primary antibodies used in this study included mouse antibodies
against SSEA3 and TRA-1-60 (Santa Cruz Biotechnology, Santa
Cruz, CA). Mouse anti-PAX6 (final dilution 1:5000), rat anti-
HOXB4 (1:20), mouse anti-MNR2 (HB9, 1:50), and rabbit anti-
bIII-tubulin (1:5000) antibodies were from Developmental Studies
Hybridoma Bank (Iowa City, IA). Goat anti-OTX2 (1:2000, R&D
Systems Inc., Minneapolis, MN), rabbit anti-TBR1(1:2000), and
mouse anti-MAP2 (1:2000) were from Chemicon (Billerica, MA),
rabbit anti-FOXG1 (1:100), mouse anti-S100b1:1 ˜ , and rat anti-
CTIP2 (1:2000) from Abcam (Cambridge, MA), rabbit anti-
VGLUT1 (1:1000) from SYSY (Germany) and rabbit anti-tyrosine
hydroxylase (TH) (1:400) from Pel-Freez (Rogers, AK), and rabbit
anti-Synapsin-I (1:250) was from Calbiochem (Gibbstown, NJ).
The inhibitor of FGF receptors SU5402 was from Pharmacia &
Upjohn Co. (Bridgewater, NJ).
hiPSC Generation
Human iPSC lines were established using the published
protocols[22,23,25]. The self-inactivating lentiviral (SIN) vectors
contained paired genes for reprogramming factors OCT4 and
SOX2, NANOG and LIN28 or c-MYC and KLF4, and each gene
pair was separated by an internal ribosome entry site for co-
expression driven by the EF1a promoter. These lentiviral vectors
were used as positive controls in hiPSC derivation via episomal
expression of the reprogramming factors[25]. The pMXs
retroviral vectors containing OCT4, SOX2, c-MYC, and KLF4
were from Addgene (Cambridge, MA). Lentiviral vector superna-
tants were produced by co-transfection of each lentiviral vector,
pMD2.G, and psPAX2 (Addgene) into 293FT cells (Invitrogen).
Retroviral vector supernatants were produced by co-transfection
of each retroviral vector, pMD2.G, and Gag-pol into 293FT cells
(Invitrogen). Human fetal lung fibroblast line IMR-90 purchased
from ATCC (Manassas, VA) or human dermal fibroblast line
HDFa from Invitrogen were seeded at 2610
4 cells/cm
2 or ,10
6
cells/10-cm dish (56.7 cm
2) in DMEM (Invitrogen) supplemented
with 10% FBS and 0.1 mM Non-essential Amino Acids. 10-30
colonies with morphology similar to that of hESC colonies were
observed per plate. Most of the potential colonies were picked up
and split onto mouse embryonic fibroblast (MEF) feeder cells to
derive hiPSC lines.
The resultant hiPSC lines were positive for TRA-1-60 and
SSEA4 by immunofluorescence (Figure S1A) and capable of
teratoma formation (Figure S1B). Silencing of the transgenes in the
hiPSC lines was confirmed (Figure S1C). Teratomas were usually
formed in immunocompromised SCID-beige mice about 6 weeks
after intramuscular injection of 0.05 ml hiPSC suspension into a
hind limb. The animals were euthanized and the tumors dissected
for necropsy analysis. The animal would be also euthanized in case
of any of the three conditions: (1) a bump (tumor) exceeds one cm
in diameter; (2) there is any ulceration of tumors; and (3) no
tumors formed within 20 weeks post-hiPSC injection. The animal
use protocol was approved by the Institutional Animal Care and
Use Committee according to the guidelines of the Association for
the Assessment and Accreditation of Laboratory Animal Care
International.
Cell Culture
hESC lines H9 [30] and CT2 [32,33], hiPSC lines TZ1
(generated by using the lentiviral vectors), YZ1 and YK26
(generated by using the retroviral vectors) were cultured on
irradiated mouse embryonic fibroblast (MEF) cells in hESC
medium, i.e., DMEM/F12 containing 20% KnockOut Serum
Replacer, 0.1 mM Non-essential Amino Acids, 1 mM L-gluta-
mine (all from Invitrogen), and 0.1 mM b-mercaptoethanol
(Sigma-Aldrich) and then supplemented with 4 ng/ml bFGF
(Millipore)[34]. We also used hFIB2 hiPSC line (courtesy of
George Daley)[35] generated the same way as that for YZ1 and
YK26.
Induction of Region-specific Neural Cells
For generation of region-specific neural cells from hiPSC, we
used protocols developed for the same purpose on
hESC[16,18,21]. In brief, colonies of hiPSC (and hESC as
positive control) were detached from feeder cells (at day 0) and
suspended in hESC medium (without bFGF) for 4 days. Then
these hiPSC/hESC aggregates were cultured in a neural medium
consisting of DMEM/F12 (Invitrogen), N2 supplement, and 2 mg/
ml heparin (Sigma-Aldrich, St. Louis, WA) without growth factors.
After adherence to a plastic surface on day 6, primitive
neuroepithelial (NE) cells were observed at days 8–10, followed
by treatment with or without various morphogens starting to
induce region-specific neural cells as detailed below. All the cells
further differentiated into the definite neural epithelial cells at days
14–17, and these neural progenitor cells were plated onto
ornithine/laminin-coated coverslips at day 24 for terminal
differentiation.
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condition free of known morphogens was used to generate NE
cells, which uniformly expressed anterior transcription factors such
as OTX2, LHX2 starting at day 24, but were negative for
posterior HOX proteins. For midbrain induction, the NE cells
were treated with 50 ng/ml FGF8 and 100 ng/ml SHH (R&D
Systems Inc., Minneapolis, MN) for one week starting at day 10.
For hindbrain and motor neuron induction, hESC/hiPSC-derived
NE cells were first treated with 0.1 mM RA for caudalization in the
neural medium at day 10. The NE cells in the center of colonies
formed neural tube-like rosettes and attached loosely to the Petri
dish, whereas the peripheral flat cells adhered to the dish tightly.
At day 17, the cells in the center of the colonies were gently blown
off with a 5-ml serological pipette. The flat cells on the periphery
remained attached.
After isolation, cell clumps of the RA group were suspended in
the same neural medium in the presence of 0.1 mM RA and 100–
200 ng/ml SHH, and cell clumps of the FGF8 group were
suspended in the presence of 10 ng/ml FGF8. The cell clumps
were cultured for one week (until day 24). After that, the NE
clumps were replated on poly-ornithine/laminin coated coverslips
for terminal differentiation in the presence of neural basal medium
supplemented with N2 and B27. Trophic factors each at 10 ng/ml
(all from Peprotech, Rocky Hill, NJ) including brain-derived
neurotrophic factor (BDNF), glial-derived neurotrophic factor
(GDNF), and insulin-like growth factor-1 (IGF1) were added to the
cultures of all the groups. To test the requirement of FGF
signaling, we treated some of the cells with 5 mM SU5402, a
chemical inhibitor of FGF receptors, added at days 4, 6 and 8 of
differentiation. The cells were harvested at day 10 of differenti-
ation and processed for fluorescence-activated cell sorting (FACS)
analyses as described before[21]. Data were expressed as mean 6
standard deviation. The statistical significance for comparison of
the SU5402 treated groups with the control groups was analyzed
by using Dunnett’s test.
Immunocytochemistry and Quantification
Cells were fixed with 4% paraformaldehyde for 15 min, and
incubated in PBS containing 0.2% Triton X-100 (for permea-
blization) and 10% donkey serum (for blocking). PBS containing
0.1% Triton X-100 and 5% donkey serum was used to dilute the
primary antibodies. The cells were incubated with the primary
antibodies at 4uC overnight, followed by washing with PBS for
three times. Afterwards, the cells were incubated with fluoro-
chrome-conjugated, corresponding secondary antibodies at room
temperature for 30 min and washed with PBS-T for three times.
Finally, the cells were examined under fluorescence microscope to
capture both phase and fluorescent images.
The populations of cells immunostained positive for specific
markers among total differentiated cells (all the cell nuclei were
counterstained with Hoechst) were counted as described be-
fore[16]. In brief, a Zeiss Axio Observer fluorescence microscope
(Carl Zeiss Inc., Thornwood, NY) was used to capture images.
Then at least 5 fields on each coverslip were randomly chosen and
counted [using an ImageJ software program (National Institute of
Mental Health, Bethesda, MD)] by an observer blinded to the
experimental conditions. Three to four coverslips in each group
were counted. Data were expressed as mean 6 standard deviation.
Fluorescence-Activated Cell Sorting Analysis
Cell clumps were harvested by using Accutase (Innovative Cell
Technologies Inc., San Diego, CA), and gently dissociated into
single cells. The cells were washed with a FACS buffer, which
contained PBS, 0.1% NaN3, and 2% donkey serum. After being
fixed and permeablized with ice-cold 0.1% paraformaldehyde for
10 min and 90% methanol for 30 min, the cells were incubated
overnight with the anti-PAX6 antibody or a normal mouse IgG as
a negative control at a concentration of one mg of the antibody or
IgG per 10
6 cells. The cells were then washed and incubated with
Alexa 488-conjugated donkey anti-mouse IgG for one hour
followed by three washing steps. The cells were analyzed on a
Becton Dickinson FACS Calibur instrument, and the ratio of
PAX6
+ cells was calculated by using the CellQuest Pro software
(BD Biosciences, San Diego, CA).
Low-density Array Analysis
hESC and hiPSC undergoing neural induction at various time
points were collected and subjected to RNA isolation and reverse
transcription by using a High Capacity cDNA Reverse Tran-
scription Kit (Applied Biosystems, Foster City, CA), according to
the manufacturer’s protocol. cDNA derived from approximately
100 ng RNA per sample was applied to TaqMan Human Stem
Cell Pluripotency Low-Density Array card for real-time PCR on
an ABI 7900HT Fast System. The samples were tested in triplicate
and the data analyzed with RQ2.1 software and displayed as DCt
(inversely related to mRNA level) in a scatter plot. All the array
cards, real-time PCR system, and software were from Applied
Biosystems.
RT-PCR Analysis
RNA was isolated from cells by using TRIzol reagent
(Invitrogen), and cDNA was synthesized from the RNA by using
ThermoScript (Invitrogen), according to the manufacturers’
instructions. Gene expression was assessed through PCR with
primers for specific genes (Table S1) under the following
conditions for a linear phase of amplification: an initial 5 min
denaturation at 95uC; followed by 30 cycles of 45 sec of
denaturation at 95uC, 45 sec of annealing at 55uC, and 45 sec
of extension at 72uC; and completed with a final extension at 72uC
for 10 min.
Electrophysiology
Coverslips were put in a bath solution including the following (in
mM): 1.9 KCl, 26 NaHCO3, 2.2 CaCl2, 127 NaCl, 1.2 KH2PO4,
1.4 MgSO4, 10 glucose and 10 Hepes at 305 mOsm. Tetrodotoxin
(TTX) (1 mM), 4-aminopyridine (4-AP) (1 mM) and tetraethylam-
monium (TEA) (500 mM) were applied to the cells based on the
experimental purpose. Accurate application of drugs was attained
using a gravity-fed drug barrel system and all reagents were diluted
in extracellular solution. Recording pipettes with resistances of 2–
4M V were filled with an intracellular recording solution including
the following (in mM): 10 Na
+-HEPES, 140 K-gluconate, 10
BAPTA, and 4 Mg
2+-ATP, pH 7.2, 290 mOsm. All chemicals
were purchased from Sigma. Neurons were visualized using a
Nikon Optical TE2000 microscope (Tokyo, Japan) with differen-
tial interference contrast optics at 406. Voltage-clamp and
current-clamp recordings were obtained using an Axopatch
200B amplifier (Molecular Devices, Sunnyvale, CA). Signals were
filtered at 4 kHz and sampled at 100 kHz using a Digidata 1322A
analog-to-digital converter (Molecular Devices). All data were
saved on a computer hard disk and analyzed with pClamp 9.0
(Molecular Devices). Capacitance and series resistance were
compensated (typically 50%–80%). The liquid junction potential
(,10 mV) calculated based on previously published methods[36]
(JPCalc in Clampex; Molecular Devices) was not adjusted. All
recordings were conducted at 21–23uC.
Action potential (AP) amplitude was measured from the
threshold to the peak of the voltage deflection. Na
+ and K
+
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holding potential of 2100 mV. Peak Na
+ currents and peak K
+
currents were measured using pClamp 9.0 (Molecular Devices).
Transient K
+ current amplitudes were obtained by measuring the
difference between the peak and sustained current amplitude. Na
+
currents were evaluated by using TTX-sensitive currents.
Results
hiPSC Generated by Using Different Systems Form Neural
Tube-like Rosettes in Teratomas
The hiPSC colonies started to appear among the fibroblast
transduced with the 4 or 6 reprogramming factors at 14–16 days
post-transduction. They were isolated and passaged onto new
MEF feeder cells, and cultured routinely [30]. Three resultant
hiPSC lines, TZ1, YZ1, and YK26, and the hFIB2 hiPSC line
from the Daley laboratory [35] were used in this study. TZ1, YZ1,
and YK26 were all validated by immunostaining of pluripotency
markers and teratoma formation, and all the 4 or 6 transgenes
were found silenced in the established hiPSC lines (representative
data were shown in Figure S1), The DNA fingerprints of the
hiPSC lines all matched their corresponding parental fibroblast
lines and the karotypes of the hiPSC lines were all found normal
by G-banding (data not shown). For teratoma formation, hiPSC
(,10
7 cells) grown on MEF feeder cells were harvested and
injected into the rear leg muscles of 4-week-old male SCID-beige
mice (3 mice per cell line). The mice were sacrificed around 6 to 8
weeks after injection and teratomas excised and examined
histologically. Among other germ layer structures, neural tube-
like rosettes were found within the ectodermal tissues in the
teratomas formed by the hiPSC lines (Figure S1B), which indicates
that, like hESC, the hiPSC lines we generated also possess similar
ability to form primary neural structures in vivo.
Neural Differentiation Efficiency Differs Among Various
hiPSC Lines
In vitro differentiation of hESC to the neural lineage recapitu-
lates the in vivo development in multiple aspects, including
morphology (formation of neural rosette), timing, and gene
expression. Based on our previous experiences with
hESC[3,16,37], the process of neuroectodermal differentiation
starts when hESC detach and aggregate to form embryoid bodies
(EBs). After 4-day suspension culture of hiPSC clumps in hESC
medium, the hiPSC aggregates were cultured in the neural
medium for 2 days and were then plated on a plastic surface.
Neural differentiation in the adherent colony culture was
examined daily. The attached cells formed individual colonies of
monolayer cells 1–2 days later, with increased cell density and
compaction in the center of the colonies. After around 10 days in
total of differentiation from hiPSC, the cells began to elongate and
line up radially to form distinct columns of cells, which were
morphologically distinct from the peripheral flat cells that outlined
the clusters of columnar cells (primitive NE cells). Continued
differentiation for an additional 4–5 days (totally 14–16 days)
resulted in the further compaction of the cells and formation of
defined ridges of columnar cells. These ridges of columnar cells
often formed rings with a distinct inner lumen, a structure
reminiscent of the neural tube. Thus, these cellular structures were
referred to as ‘‘neural tube-like rosettes’’ (or definite NE,
Figure 1A). The morphological changes during neural differenti-
ation were very similar between hESC and hiPSC.
We then analyzed the gene expression profiles using a low-
density array, which are shown in a heatmap (Figure 1B) with the
raw data presented Table S2. Through RT-PCR (Figure 1C), we
confirmed that expression of the pluripotency genes POU5F1
(OCT4) and NANOG decreased starting at day 6 of differentiation
from either hESC (H9) or hiPSC (YZ1). In contrast, SOX2,
expressed by both hESC/hiPSC and neural stem cells, was highly
expressed in H9, YZ1, and early neural cells differentiated from
the two cell lines. Meanwhile, expression of neural specific makers,
e.g., PAX6 and SOX1, increased during differentiation (Figures 1C).
To compare the efficiency of neural differentiation between the
different cell lines, we analyzed the ratios of PAX6
+ NE cells from
two hESC lines H9 and CT2 and four hiPSC lines YK26, YZ1,
TZ1, and hFIB2 by FACS at multiple time points (Figures 1D and
1E). As a general neural stem cell marker and early neural
transcription factor, PAX6 protein is detectable as early as day 6 of
neural differentiation from hESC [16,37]. TZ1 matched the hESC
lines very well in neural differentiation efficiency. However, YK26
and YZ1 differentiated slower than TZ1, H9, and CT2, as their
PAX6+ cell ratios lagged behind at day 10 but caught up at day
17. The fourth hiPSC line hFIB2 behaved even more differently
than the others, the hFIB2 cells attached poorly and detached
easily resulting in a decline in PAX6+ cell ratio at day 10 and no
cells available by day 17. These results suggest that heterogeneity
indeed exist among various hiPSC lines, and timing of
differentiation is also a matter.
FGF Signaling is Required for Early Neural Induction
By using the Xenopus embryo, we have previously demonstrated
that inhibition of the BMP pathway is sufficient for neural
induction[8] and activation of FGF pathway is required for both
neural induction and caudalization[38]. Other studies have
indicated the involvement of these pathways in neural differenti-
ation from mouse[39,40] and human[3,16,41] ES cells. We
noticed that expression of some FGF members (e.g., FGF8 and
FGF9) was up-regulated during early neural induction from hiPSC
as well hESC (Figure 1C), which led us to evaluate the role of the
FGF pathway during neural induction from hiPSC. We blocked
FGF signaling at the receptor level by using SU5402[42]. We
treated TZ1 hiPSC or H9 hESC with 5 mM SU5402 from days 4
through 8, and found that there were no clear morphological
differences in the beginning of the EB formation between the
treated and control cells (data not shown). The ratio of PAX6
+
cells differentiated from TZ1 dramatically declined at day 10 of
differentiation compared to that of the control groups (Figures 2B
and 2C). These data suggest that FGF signaling is required for
neural induction from hiPSC as well as hESC.
Region-specific Neural Differentiation from hiPSC
The protocols we used for generation of region-specific neural
cells from hiPSC were similar to those developed for
hESC[16,18,21] (Figure 1A). In the absence of exogenous growth
factors, NE cells differentiated from either hESC or hiPSC
expressed the anterior transcription factor OTX2, which was
detected at days 10 and 17 of differentiation (Figure 3B).
Expression of the telencephalic transcription factor FOXG1
28 was
detected in the NE cells by RT-PCR at day 17 of differentiation
(Figure 3B) and by immunostaining at day 25 of differentiation
(Figure 3D). Immunostaining at day 25 and counting of the stained
cells (see Materials and Methods) demonstrated that OTX2
+ cells
were approximately 87.865.81%, 85.566.80%, and 82.367.09%
among the NE cells differentiated from H9, TZ1, and YZ1 groups,
respectively, whereas the hindbrain marker HOXB4 was absent in
all the NE cells. The predominant and persistent expression of the
anterior markers was accompanied by lack of expression of EN1
and HOXB4, two transcriptional factors expressed in the mid/
iPSC & Region-Specific Neurons
PLoS ONE | www.plosone.org 4 July 2010 | Volume 5 | Issue 7 | e11853Figure 1. Comparison of neural induction from hiPSC and hESC. (A) Morphological changes during neural differentiation from hiPSC. Left to
right panels are a hiPSC colony (iPSC - referred to as day 0 of differentiation hereafter), a day-6 EB (d6), day-10 primitive NE cells (d10), and day-17
definitive NE cells (d17). (B) Low-density array for gene expression profile in H9 hESC and TZ1 hiPSC during their neural differentiation. Left to right
lanes are day 0, 6, 10 and 17 samples as described in A. Green color refers to low gene expression (high DCt value) and red to high gene expression
(low DCt value). (C) RT-PCR confirmation of the expression patterns of some pluripotent genes and neural differentiation genes. (D) Representative
histograms for FACS analysis for ratio of PAX6
+ cells differentiated from TZ1 and YZ1 at day 10. (E) Bar chart for FACS analysis for ratio of PAX6
+ cells
at three time points of neural differentiation from two hESC lines and four hiPSC lines. Data from multiple biological replicates are presented as mean
6 standard deviation. N.A. stands for not available.
doi:10.1371/journal.pone.0011853.g001
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(Figure 3B).
To test whether these forebrain neural progenitors could be
caudalized by addition of morphogens, we added 50 ng/ml FGF8
(for induction of the midbrain cells) or 0.1 mM RA (for induction
of the midbrain and hindbrain cells) to the culture of the NE cells
starting at day 10 of differentiation. Treatment with FGF8 induced
expression of the midbrain marker EN1 at day 17 (the d17F lane in
Figure 3B) in the NE cells differentiated from both hiPSC and
hESC groups. In contrast, treatment with RA induced NE cells
from both groups to express HOXB4, a marker for the hindbrain
and spinal cord (the d17R lane in Figures 3B and 3E). At day 25,
92.765.1%, 93.264.5%, and 91.665.1% in the H9, TZ1, YZ1
groups, respectively, were positive for HOXB4 and all were
negative for OTX2 (Figure 3E). This is in sharp contrast to the
control NE cells induced in the absence of the morphogens (the
d17C lane in Figures 3B and 3C). Together, these data suggest
that hiPSC-derived NE cells can be efficiently caudalized along the
anterior-posterior axis following treatment with these morphogens.
Differentiation of Functional Neurons from Region-
specific Progenitors
Among the most common neurotransmitters in the brain,
glutamate mainly initiates excitatory signals and GABA initiates
inhibitory signals. Differentiation into glutamatergic and GA-
BAergic neurons indicates the maturation of the forebrain
progenitors. To test this maturation, we plated hESC/hiPSC-
derived forebrain progenitor cells on coverslips for differentiation
in the absence of morphogens for 5 weeks. At this time point, a
large population (.60%) of cells expressed TBR1 (Figures 4A and
4F), a transcriptional factor expressed by glutamatergic neurons,
and many TBR1
+ neurons also expressed microtubule-associated
protein 2 (MAP2), a mature neuron marker (Figure 4A). Some
neurons were positive for CTIP2 (Figure 4B), a transcriptional
factor expressed by subcerebral projection neurons. Moreover,
almost all the CTIP2
+ cells were also positive for vesicular
glutamate transporter 1 (VGLUT1) (Figure 4B), a marker
expressed by mature glutamatergic neurons[39]. These results
indicate that the forebrain progenitors derived from hiPSC, similar
to those from hESC, can further differentiate into forebrain
glutamatergic neurons following maturation from NE cells to
dorsal telencephalic cells in absence of known morphogens.
Previously, we [21] and others [43] have shown that the above
treatments not only generate GABAergic neurons but also various
types of glia. Here we also found that S100b
+ astrocytes were
present among the cells differentiated for two months from both
H9 hESC and TZ1 hiPSC (Figure 4E). Synapsin
+ neurons were
also identified among both the H9- and TZ1-differentiated cells,
suggesting that these neurons can make synapses in the long-term
culture (Figure 4E). Percentages of cells immunostained positive
for TBR1 counted in the above assays were similar between the
hESC and hiPSC lines (Figure 4F).
Figure 2. Requirement of FGF signaling for neural induction from hiPSC and hESC. (A) Phase contrast images for EBs at day 8 of neural
differentiation from H9 hESC and TZ1 hiPSC treated with 5 mM SU5402 or vehicle (Control) from days 4 through 8. (B) Decline of PAX6
+ cell ratio
detected by FACS at day 10 of neural differentiation from H9 and TZ1 cells treated with SU5402 or vehicle on the last 6 days. (C) The decline of PAX6
+
cell ratio from B was analyzed statistically. Data are presented as mean 6 standard deviation. n=4. *P,0.05 versus the control group.
doi:10.1371/journal.pone.0011853.g002
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neurons, the NE-derived midbrain (induced by FGF8) and spinal
progenitors (induced by RA) were ventralized by treatment with
100 ng/ml SHH (R&D Systems) at days 10–17 and days 17–31,
respectively. After suspension culture in the neural medium for
one week from days 17 through 24, these neural progenitors were
plated on poly-ornithine/laminin coated coverslips for terminal
differentiation. Following another 2-week differentiation (totally 5
weeks), dopaminergic (TH
+) and spinal motor (HB9
+) neurons
were generated from the FGF8/SHH- and RA/SHH-treated NE
cells, respectively (Figures 4C and 4D). Counting of the positively
immunostained neurons showed comparable ratios of the TH
+
(,10%) and HB9
+ (,20%) neurons among differentiated cells
from H9, TZ1, and YZ1 cell lines (Figure 4F).
To determine the function of the hiPSC-derived neurons, we
examined the electrophysiological properties of neurons at 6–8
weeks of differentiation from TZ1 hiPSC, in comparison to those
from H9 hESC. Neurons differentiated from both H9 and TZ1
cells in the basic condition without exogenous morphogens had a
similar ability to fire action potentials (APs) in response to
depolarizing current pulses (Figure 5A). Notably, both Na
+
currents and K
+ currents contribute to the APs detected from
both groups of neurons. Large and rapidly activating inward
currents were reliably induced by voltage steps from a holding
potential of 2100 mV (Figure 5Bi) and were blocked completely
by TTX applied to the extracellular solution (Figure 5Bii).
To determine whether outward K
+ currents contributed to the
APs, we analyzed outward currents in response to voltage steps
from a holding potential of 2100 mV (Figure 5Ci). We observed
two distinct K
+ current components. The transient outward
current could be isolated by subtracting the 4-AP-treated current
(Figure 5Cii) from the untreated current, the remaining sustained
current was present in all cells and could be reduced with 0.5 mM
TEA (Figure 5Ciii). Similar results were obtained between
recordings of the above electrophysiological parameters on 30
H9-derived and 40 TZ1-derived neurons (Table S3). These results
suggest that differentiating neuronal cells from hESC and hiPSC
are functionally alike to each other, as both can fire APs, and gain
characteristic Na
+ and K
+ currents at 6–8 weeks of differentiation.
The ability of the neurons to fire APs appears age-dependent
because we did not detect APs and Na+/K+ currents in younger
neurons (data not shown).
Figure 3. Differentiation of hiPSC/hESC-derived NE cells into region-specific neural progenitors. (A) Schematic for protocols to generate
region-specific neural progenitors. (B) RT-PCR analysis for expression of anterior-posterior neural marker genes at days 10 (d10) and 17 (d17) of neural
differentiation from H9 hESC and TZ1 and YZ1 hiPSC lines. The day-17 cells were treated with RA (d17R) or FGF8 (d17F) for the last 7 days with
untreated cells as a control (d17C). (C&D ) Immunostaining for OTX2 and HOXB4 (C) or FOXG1 (D) on neural progenitors differentiated for 25 days
from H9, TZ1, and YZ1. Cell nuclei were counterstained with Hoechst 33342. Bar, 50 mm. (E) The same staining on neural progenitors differentiated for
25 days from the 3 cell lines that were treated with RA.
doi:10.1371/journal.pone.0011853.g003
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A paucity of reliable neural disease models has been a major
hurdle for studying pathologic mechanisms, screening new drugs,
and developing new therapies to treat neural degenerative
diseases. Similar to hESC, hiPSC derived from somatic cells
possess self-renewal and pluripotency properties and are expected
to serve as a powerful tool to model diseases for basic and
Figure 4. Further differentiation of hiPSC/hESC-derived neural progenitors into region-specific neurons and astrocytes. (A&B )
Immunostaining for the forebrain functional markers TBR1 and MAP2 (A), and CTIP2 and VGLUT1 (B) on cells differentiated for 5 (A)o r6( B) weeks
from H9 hESC and TZ1 and YZ1 hiPSC lines. (C) Immunostaining for the dopaminergic neuron marker TH on cells differentiated from hESC/hiPSC-
derived and FGF8/SHH-treated neural progenitors. (D) Immunostaining for the spinal motor neuronal marker HB9 (with bIII-tubulin as a neuronal
control marker) on cells differentiated from hESC/hiPSC-derived and RA/SHH-treated neural progenitors. (E) Some cells were positive for S100b (an
astrocyte marker) or Synapsin at two months after differentiation from H9 or TZ1 cells. Cell nuclei were counterstained with Hoechst 33342. Bar,
50 mm. (F) Percentage of cells immunostained positive for TBR1, HB9, and TH counted for A, C, and D, respectively.
doi:10.1371/journal.pone.0011853.g004
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been made to explore the similarities and differences between
hESC and hiPSC at the pluripotent stage[44], little is known about
whether these two cell types have similar abilities to differentiate
into functional cells of specific lineages. In this paper, we have
demonstrated differentiation of hiPSC into a spectrum of region-
specific neural progenitors, which further develop into functional
neurons. We have also revealed the heterogeneity among various
hiPSC lines to undergo neural differentiation.
Neural induction is the first step during neural develop-
ment[45,46]. hESC differentiation into neural cells can be
triggered and enhanced in vitro by using morphogens such as
BMP antagonists and FGF agonists that are also critical for in vivo
development of the neural ectoderm[3,47,48]. By applying a BMP
antagonist alone or together with SB431542 (a small molecule
inhibitor of the Nodal/Activin/TGFb pathway), both hESC and
hiPSC can be efficiently differentiated into NE cells[4]. Another
commonly used method for neural induction is via EB formation
in a chemically defined system including a minimum medium,
which mimics the development of neural ectoderm cells in
morphology and gene expression profiles[3,5,37]. Although
addition of bFGF into this system may increase the number of
NE cells, NE cells can be efficiently generated from hESC without
bFGF. Further analysis has shown that endogenous FGF
contributes to this process, irrespective of the inhibition of BMP
signaling[49]. In our present study, we used a chemically defined
system and carefully analyzed the initial and terminal neural
differentiation of various hiPSC lines in comparison to the H9
hESC line. We found that the morphological changes and gene
expression patterns during neural differentiation from hiPSC are
very similar to those for hESC. Addition of SU5402, the inhibitor
of FGF receptors, significantly decreased the generation of PAX6
+
NE cells, which suggests that FGF signaling is also required for
neural induction from hiPSC as well as hESC.
Using FACS analysis to quantify PAX6
+ NE cells, we compared
the neural differentiation efficiency among four hiPSC lines and
two hESC lines (Figure 1E). We observed three scenarios in terms
of the differentiation efficiency: 1) comparable with hESC (for
TZ1); 2) low but eventually catching up (for YK26 and YZ1); and
3) poor due to cell attachment problem (for hFIB2). These
variations suggest that heterogeneity indeed exists among various
hiPSC lines, which has also been shown in a recent study [43].
The reasons for the heterogeneity are not clear. Recent studies
showed quite different gene expression patterns and miRNA
expression profiles among various hiPSC lines [44,50]. Even the
gene expression pattern for late-passage hiPSC is different from
that for early-passage hiPSC[44]. Our low-density array data also
showed marked variations between the YZ1 hiPSC line and H9
Figure 5. hiPSC-derived neurons are functional in vitro. (A) Action potentials (APs) were observed, representative voltage responses to a 20 pA
current injection are shown for neurons following 6 weeks of differentiation from H9 and TZ1 cells in the basic neural induction condition without
exogenous morphogens. (B)( i) Rapidly activating and inactivating voltage-gated inward currents were elicited by depolarizing to various voltages
from a holding potential of 2100 mV. (ii) The inward currents were completely blocked by TTX (1 mM). (iii) TTX-sensitive Na
+ current in H9 and TZ1
cells. (C)( i) Representative traces showing fast inactivating and sustained-outward currents elicited by voltage steps from a holding potential of
2100 mV. 4AP (1 mM) eliminated the fast inactivating K
+ current, and TEA (0.5 mM) blocked the sustained currents. (ii) 4AP-sensitive K
+ currents. (iii)
TEA-sensitive K
+ currents. Values of the electrophysiological parameters detected in representative neurons differentiated from both H9 and TZ1 cells
are shown in Table S3.
doi:10.1371/journal.pone.0011853.g005
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differentiation. Whether the variations in neural differentiation
efficiency are due to differences in pluripotency levels or other
intrinsic nature of the cell lines awaits further investigation. Our
results also argue for the importance to use multiple hiPSC lines
and test at multiple time points before a conclusion is drawn as
both cell line heterogeneity and differentiation timing are impact
factors.
Although differentiation of dopaminergic neurons and motor
neurons from hiPSC has been reported[4,51], the ability of
hiPSC/hESC-derived NE cells to further differentiate into various
region-specific progenitors is largely unknown. In this paper, we
induced hiPSC differentiation into a spectrum of region-specific
neural cells by using various morphogens and compared the
efficiency of such differentiation between various hiPSC lines.
Although we observed different efficiencies of neural induction
from various hiPSC lines, NE cells derived from both TZ1 and
YZ1 could further differentiate into forebrain, midbrain, and
spinal cord progenitors. The generation of the region-specific
neural cells positive for FOXG1, OTX2 or HOXB4 was
comparable between TZ1 and YZ1 hiPSC, and H9 hESC. These
neural progenitors could further differentiate into functional
glutamatergic, dopaminergic, and spinal motor neurons as well
as astrocytes by using protocols developed for hESC[16,18,21].
Together, our work has demonstrated that hiPSC, regardless how
they are derived, can generate region-specific neurons including
the forebrain glutamatergic neurons.
Supporting Information
Figure S1 Characterization of hiPSC. (A) Immunostaining for
pluripotency markers SSEA4 and TRA-1-60 on H9 hESC and
TZ1 and YZ1 hiPSC lines. (B) Teratomas formed at 6-8 weeks
after TZ1, YZ1, and YK26 cells were injected intramuscularly into
NOD/SCID mice. Representative tissues from the three germ
layers are shown. (C) RT-PCR analysis for expression of the
reprogramming/pluripotency genes in H9, TZ1, and YZ1 cells.
Primers that recognized both the endogenous (Endo) and total
(Total) genes (including the transduced genes) were used to detect
the silencing of the transduced genes.
Found at: doi:10.1371/journal.pone.0011853.s001 (7.91 MB TIF)
Table S1
Found at: doi:10.1371/journal.pone.0011853.s002 (0.04 MB
DOC)
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